BOSTON – An evolving understanding of cancer that incorporates the physical properties of tumors and their surrounding tissues into existing biologic and genetic models can direct cancer researchers down previously uncharted avenues, potentially leading to new drugs and new treatment strategies, say investigators from Massachusetts General Hospital (MGH), Harvard Medical School (HMS) and the Ludwig…
For Black LGBQ+ Americans, Intersectional Experiences Can Hurt — Or Help, YSPH Study FindsUsing a new method for quantifying intersectional experiences, a new Yale School of Public Health study finds that Black LGBQ+ Americans tend to feel better about themselves after encountering events that affirm their identity. In the study, which was recently published in…
Emanuel Petricoin, III, Co-Director, Center for Applied Proteomics and Molecular Medicine (CAPMM), received $280,696 from Gateway for Cancer Research for: “Discovery of Protein Biomarkers for Response Prediction to Novel Phase II Targeted Therapy Agents for Stage II/III Breast Cancer Patients in the ISPY2 TRIAL.” This funding began in October 2020 and will end in late…
Like a specter, the question looms: How risky is trick-or-treating with SARS-Cov-2, the virus that causes COVID-19, in the air — and possibly on the candy? In a study published October 30, 2020 in the journal mSystems, researchers at University of California San Diego School of Medicine and San Diego State University analyzed the viral…
COPD is a common respiratory condition and one of the top causes of hospital admissions each year, particularly during winter months. In the UK it accounts for over 140,000 hospital admissions and one million bed days at a major cost to the NHS. At a time when fewer people are able to access face-to-face consultations…
Researchers from the University of Kent, the Goethe-University in Frankfurt am Main (Germany), and the Hannover Medical School (Germany) have identified a drug with the potential to provide a treatment for COVID-19. The international team led by Professor Martin Michaelis, Dr Mark Wass (both School of Biosciences, University of Kent), and Professor Jindrich Cinatl (Institute…
Washington, DC – October 30, 2020 – New research shows that COVID-19 exposure risk from contaminated candy could be successfully mitigated both by washing hands and washing candy using a simple at-home method. A team of researchers published this work today in mSystems, an open-access journal of the American Society for Microbiology. The researchers enrolled…
The uncertainty and confusion caused by the COVID-19 pandemic is being “widely exploited by terror groups for spinning a plethora of sinister schemes”, which could lead to a new tide of violence against people and governments. This is the claim of a new international study published in the peer-reviewed Global Security: Health, Science and Policy,…
Boston – While current antiretroviral treatments for HIV are highly effective, data has shown that people living with HIV appear to experience accelerated aging and have shorter lifespans – by up to five to 10 years – compared to people without HIV. These outcomes have been associated with chronic inflammation, which could lead to the…
CAMBRIDGE, MA – October 27, 2020— In a preprint paper, “Impact of Glucose-Lowering Drugs on Mortality and Other Adverse Outcomes in Patients with Type 2 Diabetes Admitted for COVID-19,” researchers conclude a neutral effect on mortality and other adverse outcomes. Though, given the close relationship between diabetes and COVID-19, they call for more prospective studies.…